Catalyst Wire Dossier Catalyst Wire Dossier

Tizveni

tislelizumab · BeiGene Ireland Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tizveni, covering 2024-08-02 to 2024-08-02. Get the full timeline:

Most recent: EMA Withdrawn: Tizveni (tislelizumab) — BeiGene Ireland Ltd

See pricing